LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers
1 other identifier
interventional
182
1 country
1
Brief Summary
The proposed Phase 2 project will involve the further development and evaluation of LEAD IT!, which is a tablet-based app designed to enable persons with dementia to lead activities for their peers (i.e., other persons with dementia). The study will examine the clinical outcomes of long-term use of the app by both Resident Leaders (RLs) and Resident Players (RPs). The Specific Aims of the proposed Phase 2 project are to:
- 1.Develop improved Beta 1 and Beta 2 Versions of LEAD IT! with sufficient content to facilitate six activities twice per week for 4.5 months.
- 2.Examine the extent to which RLs are able to serve as leaders while using LEAD IT!
- 3.Examine the effects of resident-led LEAD IT! programming on RPs.
- 4.Examine PWD and staff satisfaction with LEAD IT!
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 10, 2020
CompletedFirst Submitted
Initial submission to the registry
August 10, 2022
CompletedFirst Posted
Study publicly available on registry
August 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 11, 2023
CompletedResults Posted
Study results publicly available
December 2, 2024
CompletedDecember 2, 2024
May 1, 2024
2.6 years
August 10, 2022
May 22, 2024
October 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change From Baseline to Treatment for Constructive Engagement on the Menorah Park Engagement Scale [Time Frame: Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Constructive Engagement on the Menorah Park Engagement Scale is defined as doing or commenting on something related to the target activity. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Constructive Engagement is zero (0) and the maximum score is two (2). Higher scores represent a better outcome.
Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Change From Baseline to Treatment for Passive Engagement on the Menorah Park Engagement Scale
Passive Engagement on the Menorah Park Engagement Scale is defined as listening or watching something related to the target activity.During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Passive Engagement is zero (0) and the maximum score is two (2). Higher scores represent a better outcome..
Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Change From Baseline to Treatment for Other Engagement on the Menorah Park Engagement Scale
Other Engagement on the Menorah Park Engagement Scale is defined as doing, commenting, listening, or watching something NOT related to the target activity. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Other Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.
Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Change From Baseline to Treatment for Non Engagement on the Menorah Park Engagement Scale
Non-Engagement on the Menorah Park Engagement Scale is defined as sleeping and/or staring into space. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Non-Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.
Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Change From Baseline to Treatment for Pleasure on the Menorah Park Engagement Scale
Pleasure on the Menorah Park Engagement Scale is defined as clearly observable laughing or smiling. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Pleasure is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.
Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Secondary Outcomes (4)
Change From Baseline to Treatment on Dementia Related Quality of Life (DEMQOL)
Baseline (Month 1) and Post-Treatment (Month 4)
Change From Baseline to Treatment on the Neuropsychiatric Inventory-Nursing Home (NPI-NH), Frequency x Severity Score (FxS)
Baseline (Month 1) and Post-Treatment (Month 4)
Change From Baseline to Treatment on the Geriatric Depression Scale-Short Form (GDS-SF)
Baseline (Month 1) and Post-Treatment (Month 4)
Change From Baseline to Treatment on the Cohen Mansfield Agitation Inventory (CMAI)
Baseline (Month 1) and Post-Treatment (Month 4)
Study Arms (2)
Experimental: Experimental, LEAD IT! Programming
EXPERIMENTALParticipants in the Experimental / LEAD IT! arm will take part in LEAD IT! programming for 18 weeks. The programming will occur twice per week, for a total of 36 sessions.
No Intervention: Control, Standard Care / Programming
NO INTERVENTIONParticipants in the Control arm will receive standard care / programming.
Interventions
LEAD IT! is an intervention that enables persons with dementia to lead activities for their peers. The activities take place on tablets.
Eligibility Criteria
You may qualify if:
- Must reside in an Assisted Living Facility or NH
- Must be at least 65 years old
- Must speak and read English
- Must have a clinical diagnosis of dementia (any type).
- Resident-players must score at least five on the Mini-Mental State Examination (MMSE)
- Resident-leaders must score at least 13 on the MMSE
- Resident-leaders must possess at least 70% of the characteristics of successful leaders, based upon the I'm Still Here Skills Inventory, Short Edition, Modified
You may not qualify if:
- Must be at least 18 years old
- Must speak English
- n/a
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hopeful Aginglead
Study Sites (1)
The Hearthstone Institute, LLC
Winchester, Massachusetts, 01890, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Michael Skrajner
- Organization
- Hopeful Aging
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Skrajner, MA
Hearthstone
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2022
First Posted
August 25, 2022
Study Start
November 10, 2020
Primary Completion
June 11, 2023
Study Completion
June 11, 2023
Last Updated
December 2, 2024
Results First Posted
December 2, 2024
Record last verified: 2024-05